Developing therapeutically more efficient Neurturin variants for treatment of Parkinson's disease

Pia Runeberg-Roos, Elisa Piccinini, Anna-Maija Penttinen, Kert Matlik, Hanna Heikkinen, Satu Kuure, Maxim M. Bespalov, Johan Peranen, Enrique Garea-Rodriguez, Eberhard Fuchs, Mikko Airavaara, Nisse Kalkkinen, Richard Penn, Mart Saarma

Research output: Contribution to journalArticleScientificpeer-review

Original languageEnglish
JournalNeurobiology of Disease
Volume96
Pages (from-to)335-345
Number of pages11
ISSN0969-9961
DOIs
Publication statusPublished - Dec 2016
MoE publication typeA1 Journal article-refereed

Fields of Science

  • NRTN
  • Neurturin
  • GDNF
  • GFR alpha l
  • GFR alpha 2
  • RET
  • Heparan sulfate
  • Heparin
  • Parkinson's disease
  • Growth factor
  • MIDBRAIN DOPAMINERGIC-NEURONS
  • NEUROTROPHIC FACTOR
  • HEPARIN-BINDING
  • RECEPTOR-BINDING
  • CONTROLLED-TRIAL
  • MESSENGER-RNA
  • GENE-TRANSFER
  • INFUSION
  • GFR-ALPHA-1
  • 3112 Neurosciences
  • 3124 Neurology and psychiatry

Cite this